Equities

Acadia Healthcare Company Inc

Acadia Healthcare Company Inc

Actions
Health CareHealth Care Providers
  • Price (USD)71.78
  • Today's Change0.52 / 0.73%
  • Shares traded1.13m
  • 1 Year change+5.47%
  • Beta1.3233
Data delayed at least 15 minutes, as of Jun 06 2024 21:00 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Acadia Healthcare Company, Inc. provides behavioral healthcare services across the United States. Its facilities and services are classified into various categories: acute inpatient psychiatric facilities, specialty treatment facilities, comprehensive treatment centers (CTCs) and residential treatment centers. Outpatient programs associated with its facilities are included within each respective service line. Its acute inpatient psychiatric facilities provide a high level of care in order to stabilize patients that are either a threat to themselves or to others. Its specialty treatment facilities include residential recovery facilities and eating disorder facilities. It operates over 10 CTC locations in North Carolina and 160 locations in 32 states across the country. Its residential treatment centers treat patients with behavioral disorders in a non-hospital setting. It operates a network of over 253 behavioral healthcare facilities with 11,200 beds in 38 states and Puerto Rico.

  • Revenue in USD (TTM)2.99bn
  • Net income in USD-11.30m
  • Incorporated2005
  • Employees23.50k
  • Location
    Acadia Healthcare Company IncSUITE 610, 830 CRESCENT CENTRE DRIVEFRANKLIN 37067United StatesUSA
  • Phone+1 (615) 861-6000
  • Fax+1 (615) 261-9685
  • Websitehttps://www.acadiahealthcare.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
ACHC:NSQ since
announced
Transaction
value
Undisclosed Comprehensive Treatment Center,North Carolina(3)Deal completed28 Mar 202428 Mar 2024Deal completed-8.37%--
Data delayed at least 15 minutes, as of Jun 06 2024 21:00 BST.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Surgery Partners Inc2.79bn600.00k3.51bn10.50k9,078.951.7812.691.260.0030.00322.1415.480.410424.895.90266,142.802.331.173.201.6333.7326.335.673.031.562.470.4606--8.039.1478.21--17.41--
CorVel Corp795.31m76.25m4.11bn4.87k54.5716.5940.065.164.404.4045.8514.461.87--8.93163,308.2017.9714.8730.7324.2121.5922.149.599.16----0.000.0010.685.9514.9010.5713.87--
Radnet Inc1.66bn21.27m4.33bn7.87k180.534.9624.142.610.32480.324824.8311.810.6159--7.88210,591.101.861.242.391.6621.9321.563.021.86--1.730.43650.0013.0510.64-71.42-37.6319.60--
Select Medical Holdings Corp6.79bn259.99m4.49bn38.40k16.563.248.290.66192.092.0954.6210.650.8726--6.37176,767.904.264.195.265.4614.4413.984.895.11--3.780.697815.305.225.5753.0311.986.50--
PACS Group Inc-100.00bn-100.00bn4.63bn32.43k--35.10----------0.8661----------------------------0.8608--28.47---25.00------
Option Care Health Inc4.43bn272.67m5.18bn5.81k19.623.6315.471.171.521.5224.808.221.3914.009.15763,044.908.553.6310.644.3522.3522.456.152.781.396.980.42640.009.0643.4277.40--24.72--
Acadia Healthcare Company Inc2.99bn-11.30m6.39bn23.50k--2.2047.812.14-0.1354-0.135432.7131.300.5667--8.17176,030.70-0.06532.32-0.07262.64-----0.11535.601.255.860.3843--12.208.99-107.93--3.34--
Ensign Group Inc3.85bn218.38m6.90bn35.30k31.934.3723.491.793.803.8066.9827.730.9431--8.00109,141.305.366.456.377.8821.5422.325.686.48--40.620.08586.5623.2716.28-6.8028.624.405.02
Chemed Corp2.29bn283.41m8.39bn15.09k29.847.0724.313.6618.5818.58150.3378.461.45138.4813.85152,017.8017.9419.5321.8624.6435.4734.6012.3612.601.88--0.01148.156.064.909.175.801.466.10
Encompass Health Corp4.96bn386.50m8.70bn22.36k22.734.9911.141.753.803.6848.7617.300.8276--8.74221,721.208.366.3710.587.9495.5095.5810.109.16--5.590.529830.7810.412.3441.314.4916.60-10.42
Data as of Jun 06 2024. Currency figures normalised to Acadia Healthcare Company Inc's reporting currency: US Dollar USD

Institutional shareholders

55.89%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 31 Mar 20248.73m9.44%
T. Rowe Price Investment Management, Inc.as of 31 Mar 20248.52m9.22%
Wellington Management Co. LLPas of 31 Mar 20247.92m8.57%
BlackRock Fund Advisorsas of 31 Mar 20247.56m8.18%
Fidelity Management & Research Co. LLCas of 31 Mar 20244.54m4.91%
Dimensional Fund Advisors LPas of 31 Mar 20243.17m3.43%
Invesco Advisers, Inc.as of 31 Mar 20243.00m3.25%
William Blair Investment Management LLCas of 31 Mar 20242.92m3.16%
SSgA Funds Management, Inc.as of 31 Mar 20242.73m2.96%
Viking Global Investors LPas of 31 Mar 20242.56m2.77%
More ▼
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.